Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-08-23Clinical Trial Update: Anti-reflux Mucosectomy (ARMS) is a Useful Therapy for Refractory Gastroesophageal Reflux Disease (RGERD) [NA]
Clinical trial update suggests anti-reflux mucosectomy (ARMS) may be a useful therapy for refractory gastroesophageal reflux disease. The tr…
-
FDA approval · 2017-08-18FDA Approved: KIRKLAND SIGNATURE ESOMEPRAZOLE MAGNESIUM — Original Application (Costco Wholesale Company)
The FDA approved the original generic application for Kirkland Signature Esomeprazole Magnesium, a generic version of esomeprazole magnesium…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis [Phase 4]
Phase 4 pharmacokinetic comparison of immediate-release and delayed-release omeprazole in patients with gastroparesis, with results posted a…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Endoscopic Implantation of Enteryx for the Treatment of GERD [NA]
Completed clinical trial evaluating endoscopic implantation of Enteryx for gastroesophageal reflux disease, with results posted in 2017.
-
CLINICAL_TRIALS research · 2017-07-19Clinical Trial Update: Radiofrequency Energy Delivery for Gastroesophageal Reflux Disease [NA]
This ClinicalTrials.gov entry describes a study evaluating radiofrequency energy delivery as a treatment for gastroesophageal reflux disease…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-07-06FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) from Wyeth/Pfizer to update the drug's labeling.
-
FDA approval · 2017-07-06FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application to authorize the intravenous formulation of Protonix (pantoprazole sodium) for specified indicat…
-
FDA approval · 2017-07-05FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Original Application (BJWC)
FDA approved Berkley and Jensen Omeprazole under an original application; the product is a proton pump inhibitor indicated for gastroesophag…
-
FDA approval · 2017-07-03FDA Approved: OMEPRAZOLE — Original Application (Golden State Medical Supply, Inc.)
FDA approves a generic omeprazole from Golden State Medical Supply, Inc. under an Original Application (ANDA 203481).
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis [Phase 2]
Zeria Pharmaceutical completed a Phase 2 clinical trial evaluating the efficacy and safety of Z-215 in erosive esophagitis. The study enroll…
-
FDA approval · 2017-06-30FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Civica, Inc.)
The FDA approved Civica, Inc.'s pantoprazole sodium original application (NDA 209463), a proton pump inhibitor for acid-related conditions a…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Efficacy of Dx-pH Probe in Diagnosing Extra-esophageal Reflux Disease [NA]
This update reports results from a completed trial evaluating the Dx-pH probe's ability to diagnose extra-esophageal reflux in patients with…
-
FDA approval · 2017-06-26FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (XLCare Pharmaceuticals Inc.)
FDA approved a supplemental application for pantoprazole sodium by XLCare Pharmaceuticals Inc., validating continued approval of their panto…
-
CLINICAL_TRIALS research · 2017-06-12Clinical Trial Update: The Effect of Chlorpromazine on Esophageal Sensitivity in Healthy Volunteers. [NA]
This clinical trial evaluates the effect of chlorpromazine on esophageal sensitivity in healthy volunteers; the current status of the study …
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus [NA]
A terminated clinical trial evaluated the effect of Zegerid on esophageal pH in patients with Barrett's esophagus and gastroesophageal reflu…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin
A completed clinical trial evaluated whether oral capsaicin can stimulate sensation and improve swallowing in people with dysphagia and gast…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Demographics and Findings of Upper Endoscopy Patients
This clinical trial update summarizes demographics and upper endoscopy findings from patients with Barrett's esophagus and gastroesophageal …
-
FDA approval · 2017-05-09FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Lansoprazole (lansoprazole) from Wal-Mart Stores Inc, related to this generic product.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: GERD Treatment With Transoral Incisionless Fundoplication (TIF) Following Hiatal Hernia Surgery
A completed clinical trial evaluated transoral incisionless fundoplication (TIF) for gastroesophageal reflux disease after hiatal hernia sur…
-
CLINICAL_TRIALS research · 2017-05-03Clinical Trial Update: Should I Continue Taking My Acid Reflux Medication? Development and Pilot Testing of a Patient Decision Aid [NA]
This completed study describes the development and pilot testing of a patient decision aid to help patients decide whether to continue proto…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Mucosal Impedance in Pediatric Population
A pediatric trial evaluating mucosal impedance as a diagnostic approach completed. It investigated Gastroesophageal Reflux Disease, Eosinoph…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Assessment of Esophageal Epithelium Integrity With Mucosal Impedance [NA]
This clinical trial update indicates that the study evaluating esophageal epithelium integrity using mucosal impedance in GERD and NERD pati…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Sleep Position May Reduce Acid Reflux Symptoms at Night [NA]
The clinical trial NCT02320968, sponsored by Vanderbilt University Medical Center, investigated whether sleep position can reduce nocturnal …
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: A Prospective Blinded Randomized Study Comparing Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-y Gastric Bypass and Their Effect on Gastro-Esophageal Reflux Disease Using 24 Horus pH Monitoring [NA]
A prospective blinded randomized study comparing laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass and their effect …
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B [Phase 4]
Phase 4 clinical trial comparing the efficacy of a one-week dual delayed-release dexlansoprazole regimen versus esomeprazole for treating gr…